XML 38 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Stockholders’ Equity - 10-K - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Private GRI
Private GRI
Redeemable Common Stock
Private GRI
Convertible promissory notes
Private GRI
Bridge promissory note
Private GRI
Common Stock
Private GRI
Additional Paid-in Capital
Private GRI
Additional Paid-in Capital
Convertible promissory notes
Private GRI
Additional Paid-in Capital
Bridge promissory note
Private GRI
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020           29,857              
Beginning balance at Dec. 31, 2020           $ 124              
Ending balance (in shares) at Dec. 31, 2021 1,116         29,857              
Ending balance at Dec. 31, 2021 $ 124       $ 124 $ 124              
Beginning balance (in shares) at Dec. 31, 2020                 3,241,215        
Beginning balance at Dec. 31, 2020         (4,945)       $ 33 $ 8,742     $ (13,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock (in shares)                 10,989        
Issuance of common stock         100       $ 0 100      
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note         150         150      
Extinguishment of accrued compensation         1,406         1,406      
Net loss         $ (1,559)               (1,559)
Ending balance (in shares) at Dec. 31, 2021   121,631     3,252,204       3,252,204        
Ending balance at Dec. 31, 2021 $ (4,848) $ 0 $ 10,430 $ (15,278) $ (4,848)       $ 33 10,398     (15,279)
Ending balance (in shares) at Mar. 31, 2022 1,116                        
Ending balance at Mar. 31, 2022 $ 124                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (302)     (302)                  
Ending balance (in shares) at Mar. 31, 2022   121,631                      
Ending balance at Mar. 31, 2022 $ (5,150) $ 0 10,430 (15,580)                  
Beginning balance (in shares) at Dec. 31, 2021 1,116         29,857              
Beginning balance at Dec. 31, 2021 $ 124       $ 124 $ 124              
Ending balance (in shares) at Sep. 30, 2022 1,116                        
Ending balance at Sep. 30, 2022 $ 124                        
Beginning balance (in shares) at Dec. 31, 2021   121,631     3,252,204       3,252,204        
Beginning balance at Dec. 31, 2021 (4,848) $ 0 10,430 (15,278) $ (4,848)       $ 33 10,398     (15,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (948)                        
Ending balance (in shares) at Sep. 30, 2022   121,631                      
Ending balance at Sep. 30, 2022 $ (5,706) $ 0 10,520 (16,226)                  
Beginning balance (in shares) at Dec. 31, 2021 1,116         29,857              
Beginning balance at Dec. 31, 2021 $ 124       124 $ 124              
Ending balance (in shares) at Dec. 31, 2022           0              
Ending balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2021   121,631     3,252,204       3,252,204        
Beginning balance at Dec. 31, 2021 $ (4,848) $ 0 10,430 (15,278) $ (4,848)       $ 33 10,398     (15,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note         60         60      
Warrant issuance             $ 30 $ 571     $ 30 $ 571  
Conversion of convertible promissory note (in shares)                 592,857        
Conversion of convertible promissory note         5,337       $ 5 5,332      
Restricted stock awards issued in satisfaction of accrued compensation         417         417      
Redemption of redeemable common stock (in shares)           (29,857)     (29,857)        
Redemption of redeemable common stock         0 $ (124)     $ 0 0      
Vesting of restricted stock (in shares)                 3,571        
Stock-based compensation         25         25      
Net loss         $ (3,217)               (3,217)
Ending balance (in shares) at Dec. 31, 2022 142,821 142,820     3,818,775       3,818,775        
Ending balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 38 16,833     (18,496)
Beginning balance (in shares) at Mar. 31, 2022 1,116                        
Beginning balance at Mar. 31, 2022 $ 124                        
Ending balance (in shares) at Jun. 30, 2022 1,116                        
Ending balance at Jun. 30, 2022 $ 124                        
Beginning balance (in shares) at Mar. 31, 2022   121,631                      
Beginning balance at Mar. 31, 2022 (5,150) $ 0 10,430 (15,580)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (295)     (295)                  
Ending balance (in shares) at Jun. 30, 2022   121,631                      
Ending balance at Jun. 30, 2022 $ (5,445) $ 0 10,430 (15,875)                  
Ending balance (in shares) at Sep. 30, 2022 1,116                        
Ending balance at Sep. 30, 2022 $ 124                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note 60   60                    
Warrant issuance 30   30                    
Net loss (351)     (351)                  
Ending balance (in shares) at Sep. 30, 2022   121,631                      
Ending balance at Sep. 30, 2022 $ (5,706) $ 0 10,520 (16,226)                  
Beginning balance (in shares) at Dec. 31, 2022           0              
Beginning balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2022 142,821 142,820     3,818,775       3,818,775        
Beginning balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 38 16,833     (18,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Warrant issuance 532   532                    
Vesting of restricted stock (in shares)   67                      
Stock-based compensation 13   13                    
Net loss (2,150)     (2,150)                  
Ending balance (in shares) at Mar. 31, 2023   142,887                      
Ending balance at Mar. 31, 2023 $ (3,230) $ 0 17,416 (20,646)                  
Beginning balance (in shares) at Dec. 31, 2022           0              
Beginning balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2022 142,821 142,820     3,818,775       3,818,775        
Beginning balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 38 $ 16,833     $ (18,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss $ (11,033)                        
Ending balance (in shares) at Sep. 30, 2023 422,333 422,333                      
Ending balance at Sep. 30, 2023 $ 2,227 $ 0 31,756 (29,529)                  
Beginning balance (in shares) at Mar. 31, 2023   142,887                      
Beginning balance at Mar. 31, 2023 (3,230) $ 0 17,416 (20,646)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Vesting of restricted stock (in shares)   23,434                      
Stock-based compensation 13   13                    
Net loss (6,746)     (6,746)                  
Ending balance (in shares) at Jun. 30, 2023   422,333                      
Ending balance at Jun. 30, 2023 4,038 $ 0 31,430 (27,392)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 326   326                    
Net loss $ (2,137)     (2,137)                  
Ending balance (in shares) at Sep. 30, 2023 422,333 422,333                      
Ending balance at Sep. 30, 2023 $ 2,227 $ 0 $ 31,756 $ (29,529)